Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

NCT06585358 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06585358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06585358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 31, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary